Clinical Trial Update: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD [NA]

View source ↗

Summary

A multicenter clinical trial evaluating the procedural safety and efficacy of ELCA in coronary artery disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• ELCA (elective laser atherectomy (ELCA))

Snippet

Sponsor: Spectranetics Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2020-09-18